Omdia: Apple and HONOR Claim Record Market Shares as Europe’s Smartphone Shipment Dips 1% in 2025
LONDON–(BUSINESS WIRE)–#Consumer–The latest research from Omdia reveals that the European smartphone market declined by 1% in 2025 to 134.2 million... Read more.
Merck Evolves Human Health Operating Structure to Support Portfolio Execution
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today highlighted steps to evolve the structure... Read more.
lululemon Announces 100th Store Opening in EMEA
Milestone location will be the first lululemon store in Poland and will open with franchise partner Arion Retail Group VANCOUVER, British Columbia–(BUSINESS... Read more.
Calix Postpones 2026 Investor Day Due to Weather Event
SAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE: CALX), today announced that it has postponed its 2026 Investor Day, originally scheduled to be held... Read more.
GeoPark Comments on Parex Resources’ Nomination of Director Candidates
Shareholders Not Required to Take Any Action at This Time BOGOTA, Colombia–(BUSINESS WIRE)–GeoPark Limited (“GeoPark” or the “Company”) (NYSE:... Read more.
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Reported fourth quarter 2025 revenues of $121.0 million with 32% year-over-year growth in exome and genome test revenue (42% excluding a one-time 2024 benefit) Accelerated... Read more.
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
HENDERSON, Nev.–(BUSINESS WIRE)–$ZURA #TeamZura—Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology... Read more.
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
– Builds on Successful 2022 Collaboration on Anito-cel, a Potentially Transformative Treatment for Patients with Multiple Myeloma – – FDA Accepted Anito-cel... Read more.
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
– Builds on Successful 2022 Collaboration on Anito-cel, a Potentially Transformative Treatment for Patients with Multiple Myeloma – – FDA Accepted Anito-cel... Read more.
Starfighters Space Founder Rick Svetkoff Steps Down after Listing on NYSE; Tim Franta Appointed as CEO
CAPE CANAVERAL, Fla.–(BUSINESS WIRE)–Starfighters Space (“Starfighters” or the “Company”) (NYSE American: FJET), the innovative aerospace company,... Read more.